SIR's tradition of strategic collaboration with corporate partners began over 40 years ago, when new devices enabled clinical pioneers to attempt the first true, minimally invasive, interventional techniques that heralded a new era in modern medicine.
The newest independent medical specialty is now the most competitive among physicians in training. Interventional radiology continues to find its mission aligned with the innovative companies that seek to advance the field by aligining strategic efforts with SIR, the largest professional organization for interventional radiologists.
To learn more about opportunities for collaboration with SIR, contact Jonas Nash, SIR director of corporate relations, (786) 512-4228.
The Corporate Ambassador Program (CAP)
The Corporate Ambassador Program (CAP) engages industry partners in SIR’s mission to improve lives through image-guided therapy. CAP provides forward-thinking companies with opportunities for strategic collaboration to advance the specialty, inform the future of IR and be recognized for their support of the field.
To learn more about the CAP Program, please contact Jonas Nash, SIR Director of Corporate Relations, (786) 512-4228.
Opportunities to exhibit
Reach SIR's receptive audience of physicain decision-makers by exhibiting at any of SIR's medical education meetings. Intensive meetings include:
Extend your reach among practicing interventional radiologists, health care and hospital administration and other key decision-makers year-round through targeted member communications like:
Or, design an email blast to engage SIR members with a specific message.
Society educational meetings present a multitude of opportunities to place your brand and products in front of practicing IRs.
Interested in purchasing an SIR Mailing List? Place an order.
SIR’s Corporate Impact Report provides an overview of the latest actions SIR and SIR Foundation have taken to advance our members, our partners and our specialty. Interventional radiology defines modern medicine, providing innovative therapies that use pioneering technologies to achieve better outcomes for patients. This is only made possible with the products and expertise shared by our corporate partners. Find out how SIR and its corporate partners are building a bright, productive and visionary future together.READ THE CORPORATE IMPACT REPORT